Headaches in teens during Pandemic linked to depression and Anxiety Tyler Morning Telegraph

Friday, July 1 2022 (HealthDay News) — In the case of adolescents, the onset of new and more severe headaches throughout the COVID-19 pandemic were linked with significantly higher depression levels and general anxiety scores, as per an analysis that was presented during the annual Congress of the European Academy of Neurology which ran between June 25 and 28 from 25 to 28 June in Vienna .

Ayse Nur Ozdag Acarli, M.D., from Ermenek State Hospital in Karaman, Turkey, and colleagues investigated the long-term effect of the COVID-19 pandemic on headaches in 851 adolescents between the ages of 10 and 18 years old. The characteristics and presence of headaches academic performance as well as exposure to COVID-19 and exposure to electronic devices were studied.

Researchers discovered that headache frequency was 98% (756/851 subjects). For those who had headaches 10 percent of them reported a new-onset headaches. In contrast, 27 and 61 percent had worsened, improved, or stable headaches and stable headache, according to the study. Reduced school performance and academic performance were more frequent for people with new-onset and worsened headache. In comparison to those who had better and stable headaches the ones with worsened or new-onset headaches were significantly more likely to have more levels of depression as well as general anxiety. When compared to the group with stable headache those with worsened headaches had significantly higher scores for coronavirus anxiety. Significant correlations were observed for the frequency of headaches and their severity with age as well as depression and anxiety.

“Although earlier studies indicated that the young population was experiencing less headaches because of the closing of schools in the first months and weeks of COVID-19, this more long-term study has revealed that the stress and strains of the epidemic eventually impacted their health,” Acarli said in a statement.

The study was supported by The Global Migraine and Pain Society.

Abstract No. EPO-070

More Information

Recent Stories You’ve Forgotten